发明授权
US08841330B2 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
有权
ω-羧基芳基取代的二苯脲作为raf激酶抑制剂
- 专利标题: Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
- 专利标题(中): ω-羧基芳基取代的二苯脲作为raf激酶抑制剂
-
申请号: US13368812申请日: 2012-02-08
-
公开(公告)号: US08841330B2公开(公告)日: 2014-09-23
- 发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
- 申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
- 申请人地址: US NJ Whippany
- 专利权人: Bayer Healthcare LLC
- 当前专利权人: Bayer Healthcare LLC
- 当前专利权人地址: US NJ Whippany
- 代理机构: Millen, White, Zelano & Branigan, P.C.
- 主分类号: A61K31/44
- IPC分类号: A61K31/44
摘要:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.